Table 4.
|
Survivors |
Nonsurvivors |
P
value |
||||
---|---|---|---|---|---|---|---|
(N = 44) | (N = 3) | ||||||
|
|
|
[n] |
|
|
[n] |
|
Age (years) |
68.0 |
(34-84) |
[44] |
69.0 |
(62-71) |
[3] |
N.S. |
Sex (male/female) |
28/16 |
|
[44] |
2/1 |
|
[3] |
N.S. |
Smoking (s/ex/n) |
4/26/14 |
|
[44] |
1/2/0 |
|
[3] |
N.S. |
HRCT patterns |
|
|
[44] |
|
|
[3] |
0.001 |
OP |
4 |
|
|
0 |
|
|
|
NSIP |
24 |
|
|
0 |
|
|
|
HP |
11 |
|
|
0 |
|
|
|
DAD |
5 |
|
|
3 |
|
|
|
Hematologic data |
|
|
|
|
|
|
|
WBC (/mm3) |
6700.0 |
(3500-14600) |
[43] |
16500.0 |
(4900-20800) |
[3] |
N.S. |
Hb (g/dL) |
11.6 |
(7.9-16.2) |
[43] |
11.2 |
(8.6-12.2) |
[3] |
N.S. |
Plt (×104/mm3) |
24.6 |
(9.7-46.9) |
[43] |
16.6 |
(8.9-40.4) |
[3] |
N.S. |
Serum markers |
|
|
|
|
|
|
|
KL-6 (U/mL) |
502.0 |
(144-3884) |
[40] |
1544.0 |
(870-2218) |
[2] |
N.S. |
SP-A (ng/mL) |
64.6 |
(35.9-310) |
[34] |
65.5 |
(43.4-87.6) |
[2] |
N.S. |
SP-D (ng/mL) |
168.5 |
(23-753) |
[38] |
315.0 |
(168-462) |
[2] |
N.S. |
HSP47 (pg/mL) |
773.5 |
(61.9-2500.8) |
[44] |
1862.4 |
(816.3-2843.9) |
[3] |
N.S. |
Respiratory parameters |
|
|
[41] |
|
|
[3] |
|
P/F ratio (mmHg) |
372.4 |
(71-542.8) |
|
179.3 |
(122.2-233.2) |
|
0.03 |
A-a DO2 (mmHg) |
24.1 |
(−11.4-474.7) |
|
168.8 |
(88.6-258) |
|
0.03 |
BAL fluid findings |
|
|
[38] |
|
|
[2] |
|
Total cell count (×105/mL) |
5.3 |
(1.4-54.9) |
|
3.28 |
(1.27-5.28) |
|
N.S. |
Macrophages (%) |
43.4 |
(4.0-85.6) |
|
65.3 |
(32.7-97.8) |
|
N.S. |
Lymphocytes (%) |
34.5 |
(1.7-95.3) |
|
16.6 |
(1.9-31.3) |
|
N.S. |
Neutrophils (%) |
3 |
(0-93.6) |
|
17.3 |
(0.4-34.3) |
|
N.S. |
Eosinophils (%) |
2 |
(0-50.8) |
|
2.22 |
(1.55-2.88) |
|
N.S. |
CD4/8 ratio | 1.42 | (0.14-10.4) | 0.58 | (0.40-0.76) | N.S. |